Baculoviral IAP Repeat Containing 2 (BIRC2) (Middle Region) Peptide
Quick Overview for Baculoviral IAP Repeat Containing 2 (BIRC2) (Middle Region) Peptide (ABIN5672951)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- YYIGPGDRVA CFACGGKLSN WEPKDDAMSE HRRHFPNCPF LENSLETLRF
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- BIRC2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BIRC2 (Baculoviral IAP Repeat Containing 2 (BIRC2))
-
Background
-
The protein encoded by this gene is a member of a family of proteins that inhibits apoptosis by binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2, probably by interfering with activation of ICE-like proteases. This encoded protein inhibits apoptosis induced by serum deprivation and menadione, a potent inducer of free radicals. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: API1, MIHB, HIAP2, RNF48, cIAP1, Hiap-2, c-IAP1
Protein Size: 569 -
Gene ID
- 329
-
NCBI Accession
- NM_001166, NP_001157
Target
-